The onset and progression of liver diseases are generally accompanied by immune-inflammatory dysregulation. Hepatic macrophages play a central role in amplifying pro-inflammatory responses, regulating oxidative stress, promoting fibrotic remodeling, and shaping the tumor immune microenvironment, rendering them important targets for precision therapy in liver diseases. In recent years, drug delivery systems targeting hepatic macrophages have been continuously developed, with strategies expanding from passive accumulation strategies to multi-tiered systems featuring ligand recognition, microenvironment-responsive delivery, biomimetic camouflage, and in situ cellular reprogramming. From the perspective of drug delivery, this review summarizes representative strategies,including lipid nanoparticles, polymeric and stimuli-responsive systems, inorganic/hybrid nanomaterials, extracellular vesicles, and cell membrane-biomimetic systems, with a focus on analyzing their applicability and limitations in different pathological contexts, such as acute liver injury, metabolic liver disease, liver fibrosis, and hepatocellular carcinoma. Furthermore, key issues including hepatic macrophage subset heterogeneity, intracellular delivery efficiency, long-term safety, and industrial feasibility are discussed, along with a clinical translation prospect in this field, aiming to provide a reference for precision therapy of liver diseases.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |